Haemonetics Limited in Harrow, HA1 2AW

Description

Data updated on: 01-11-2023

The exact day this firm was started is 24th October 1975. Established under number 01231087, the company is listed as a Private Limited Company. You can reach the office of the company during business hours under the following address: Lynwood House 373-375 Station Road, HA1 2AW Harrow. The firm name switch from Haemonetics (u.k.) to Haemonetics Limited occurred on 1st October 2002. The enterprise's SIC and NACE codes are 46900 which stands for Non-specialised wholesale trade. Haemonetics Ltd filed its account information for the financial year up to 2022-03-31. The most recent confirmation statement was released on 2023-06-28.

With two job offers since December 24, 2015, Haemonetics has been a relatively active employer on the employment market. On November 30, 2017, it was seeking candidates for a full time Support & Implementation Specialist post in Coventry, and on December 24, 2015, for the vacant post of a full time Territory Sales Manager in Coventry.

The data obtained regarding this company's management reveals there are four directors: Floriane G., Roberto N., James D. and Craig G. who joined the company's Management Board on 16th July 2024, 22nd June 2022 and 24th October 2016.

Previous company's names
Haemonetics Limited 2002-10-01
Haemonetics (u.k.) Limited 1975-10-24

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	2 419 616	2 511 414	1 876 869	2 112 497

Balance Sheet
Cash Bank On Hand				989 423	592 667	2 219 319	1 295 843	2 292 847	1 823 176	5 593 396
Current Assets	2 484 225	4 667 029	2 976 651	2 857 338	2 663 126	4 619 688	3 839 917	5 695 965	4 772 995	9 114 186
Debtors	1 653 095	2 959 845	1 733 251	1 552 383	1 935 441	2 264 793	2 412 236	3 311 393	2 851 882	3 401 576
Net Assets Liabilities				2 112 497	2 445 239	2 925 216	3 280 816	46 009 107	45 039 949	46 485 907
Other Debtors		2 396	2 396	2 396	164 418	83 018	194 472	178 506	367
Property Plant Equipment				1 809 240	1 593 428	1 277 844	1 300 596	881 792	867 935	608 440
Total Inventories				315 532	135 018	135 576	131 838	91 725	97 937	119 214
Cash Bank In Hand	612 584	1 554 075	938 182	989 423
Intangible Fixed Assets	804 198	2 032 689	1 080 471	924 067
Stocks Inventory	218 546	153 109	305 218	315 532
Tangible Fixed Assets	1 284 048	1 515 742	1 626 383	1 809 240
Trade Debtors	1 259 092	2 659 400	1 298 217	1 255 224

Capital & Reserves
Called Up Share Capital	50 000	50 000	50 000	50 000
Profit Loss Account Reserve	2 369 616	2 461 414	1 826 869	2 062 497
Shareholder Funds	2 419 616	2 511 414	1 876 869	2 112 497

Other Financial Data
Audit Fees Expenses			12 000	14 000	14 000			16 250	20 000	18 000
Other Non-audit Services Fees				17 000	14 000			18 073	19 273	16 193
Taxation Compliance Services Fees				5 450	2 900					3 000
Accrued Liabilities Deferred Income				1 078 521	1 106 521			392 003	343 759	529 631
Accrued Liabilities Not Expressed Within Creditors Subtotal								66 068	71 712	169 696
Accumulated Amortisation Impairment Intangible Assets				2 245 515	2 736 057	2 772 886	1 637 914	1 709 239	1 780 564	1 851 889
Accumulated Depreciation Impairment Property Plant Equipment				2 790 107	3 004 071	3 119 198	3 494 545	2 198 395	2 377 132	2 469 347
Additions Other Than Through Business Combinations Property Plant Equipment					235 557				561 814	75 720
Administrative Expenses	2 387 971	2 794 095	2 902 163	2 524 121	2 748 753			3 561 550	3 506 539	3 190 003
Amortisation Expense Intangible Assets								71 325	71 325	71 325
Amortisation Impairment Expense Intangible Assets								71 325	71 325	71 325
Amounts Owed By Related Parties					55 538	84 743
Amounts Owed To Group Undertakings					391 389	1 541 902	422 563	1 799 524	1 858 196	1 618 282
Average Number Employees During Period				35	34			33	31	29
Bank Borrowings Overdrafts			1 963 285	1 463 283
Cash Cash Equivalents Cash Flow Value							1 295 843	2 292 847	1 823 176	5 593 396
Cash Flows From Disposal Or Reduction In Control Over Subsidiaries Or Other Businesses								42 383 234
Comprehensive Income Expense				235 628	332 742
Corporation Tax Payable				25 200	119 026	98 044	42 686	6 038	-26 993	289 927
Corporation Tax Recoverable				167 512
Cost Inventories Recognised As Expense Gross				4 844 738	4 790 657
Cost Sales	4 079 082	9 013 924	5 620 644	5 134 046	5 120 446			6 818 236	6 984 529	7 390 034
Creditors				1 463 283	2 110 958	31 533	2 088 302	3 059 579	2 998 734	5 446 055
Current Tax For Period				25 200	118 891			83 966	13 955	359 082
Debt Securities Held				1 257 620	1 776 222
Decrease From Reversal Impairment Loss Recognised In Profit Or Loss Property Plant Equipment									26 900	16 400
Deferred Income					961 605	31 533		573 930	525 727	2 230 405
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences				146 008	-68 201			-16 483	16 207	19 108
Depreciation Expense Property Plant Equipment								381 557	315 916	253 731
Depreciation Impairment Expense Property Plant Equipment								397 857	289 016	237 331
Dividend Income From Group Undertakings									59 132 190	133 569 785
Dividends Paid									60 141 271	133 569 785
Dividends Paid Classified As Financing Activities										-133 569 785
Dividends Paid On Shares							325 371
Dividends Paid On Shares Interim									60 141 271	133 569 785
Dividends Received Classified As Investing Activities									-59 132 190	-133 569 785
Finished Goods Goods For Resale	218 546	153 109	305 218	315 532	135 018			91 725	97 937	119 214
Fixed Assets	2 088 246	3 548 431	2 706 854	2 733 307	2 026 953		1 625 967	43 519 072	43 433 890	43 103 070
Further Item Increase Decrease In Equity From Share Capital Changes Dividend Payments Component Total Increase Decrease In Equity From Share Capital Changes Dividend Payments										-39 001 549
Further Item Interest Expense Component Total Interest Expense								503	53	100
Further Item Tax Increase Decrease Component Adjusting Items				-28 757	-43 339			-16 483	365 045	19 108
Future Minimum Lease Payments Under Non-cancellable Operating Leases							193 365	101 832	291 113	218 814
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss				-19 855	8 676			-1 424	-21 711	-3 710
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables								-1 198 306	60 115 238	-523 707
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables								899 157	-459 511	549 694
Gain Loss In Cash Flows From Change In Deferred Income								190 381	53 847
Gain Loss In Cash Flows From Change In Inventories								-40 113	6 212	21 277
Gain Loss On Disposals Property Plant Equipment				-12 560	2 346			23 948	80 859	106 981
Gross Profit Loss	2 379 101	3 356 684	2 916 747	2 855 611	3 017 051			3 959 166	3 937 293	5 012 989
Impairment Loss Property Plant Equipment								-16 300
Impairment Reversal Property Plant Equipment									-26 900	-16 400
Income Taxes Paid Refund Classified As Operating Activities				-92 286	142 447			-105 411	-409 668	-41 035
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation				-51 241	396 756			-997 004	469 671
Increase Decrease In Current Tax From Adjustment For Prior Periods								-12 839	-2 363	-1 127
Increase From Amortisation Charge For Year Intangible Assets					88 443	36 829	71 325	71 325	71 325	71 325
Increase From Depreciation Charge For Year Property Plant Equipment					373 815	351 941	397 115	381 557	315 916	253 731
Increase From Impairment Loss Recognised In Profit Or Loss Intangible Assets					402 099
Increase From Impairment Loss Recognised In Profit Or Loss Property Plant Equipment							27 000	16 300
Intangible Assets				924 067	433 525	396 696	325 371	254 046	182 721	111 396
Intangible Assets Gross Cost				3 169 582	3 169 582	3 169 582	1 963 285	1 963 285	1 963 285
Interest Expense On Obligations Under Finance Leases Hire Purchase Contracts				178 629	206 103
Interest Payable Similar Charges Finance Costs				45 716	4 866			503	53	100
Interest Received Classified As Investing Activities								-224	-2 066	-135
Investments Fixed Assets								42 383 234	42 383 234	42 383 234
Investments In Subsidiaries								42 383 234	42 383 234	42 383 234
Issue Equity Instruments								42 383 234
Net Cash Flows From Used In Financing Activities				500 002	1 463 283			-42 383 234
Net Cash Flows From Used In Investing Activities				544 320	155 656			42 338 115	-58 939 956
Net Cash Flows From Used In Operating Activities				-1 095 563				-951 885	59 409 627	-3 640 940
Net Cash Generated From Operations				-1 233 565				-1 057 799	58 999 906	-3 682 075
Net Current Assets Liabilities	333 595	966 349	1 189 376	1 044 556	552 168	1 419 598	1 751 615	2 636 386	1 774 261	3 668 131
Net Finance Income Costs				1 062				224	59 134 256	133 569 920
Net Interest Paid Received Classified As Operating Activities				-45 716	-4 866			-503	-53	-100
Number Shares Issued Fully Paid							50 000
Operating Profit Loss	111 130	682 589	134 584	451 490	388 298			397 616	430 754	1 822 986
Other Creditors					1 164 321	1 388 281	1 157 143	49 015	64 900	61 759
Other Disposals Decrease In Amortisation Impairment Intangible Assets							1 206 297
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment					159 853	236 814	48 766	1 694 007	110 279	145 116
Other Disposals Intangible Assets							1 206 297
Other Disposals Property Plant Equipment					237 408	351 208	274 042	2 172 675	396 934	243 000
Other Interest Income								224	2 066	135
Other Interest Receivable Similar Income Finance Income				1 062				224	59 134 256	133 569 920
Other Operating Income Format1				120 000	120 000
Other Taxation Social Security Payable					327 582	131 476	331 477	259 984	232 797	729 741
Par Value Share		1	1	1			1
Pension Other Post-employment Benefit Costs Other Pension Costs				85 290	98 132			154 047	132 740	131 182
Percentage Class Share Held In Subsidiary									100	100
Prepayments Accrued Income								177 879	205 968	138 827
Proceeds From Issuing Shares								-42 383 234
Proceeds From Sales Property Plant Equipment				-136 797	-79 901			-502 616	-367 514	-204 865
Profit Loss				235 628	332 742			345 057	59 172 113	135 015 743
Profit Loss On Ordinary Activities Before Tax	110 834	168 816	-657 701	406 836	383 432			397 337	59 564 957	135 392 806
Profit Loss Subsidiaries									62 278 662	29 858 833
Property Plant Equipment Gross Cost				4 599 348	4 597 497	4 397 042	4 795 141	3 080 187	3 245 067	3 077 787
Provisions For Liabilities Balance Sheet Subtotal				202 083	133 882	137 389	96 766	80 283	96 490
Purchase Property Plant Equipment				-682 177	-235 557			-457 721	-561 814	-75 720
Repayments Borrowings Classified As Financing Activities				-500 002	-1 463 283
Social Security Costs	170 799	224 462	232 197	217 746	219 369			257 347	246 059	285 573
Staff Costs Employee Benefits Expense				1 364 368	1 230 715			2 548 825	2 364 131	2 577 158
Taxation Including Deferred Taxation Balance Sheet Subtotal				202 083	133 882			80 283	96 490	115 598
Tax Decrease Increase From Effect Revenue Exempt From Taxation										20 326
Tax Expense Credit Applicable Tax Rate								75 494	11 317 342	25 724 633
Tax Increase Decrease Arising From Group Relief Tax Reconciliation								-1 127
Tax Increase Decrease From Effect Capital Allowances Depreciation				101 639	74 763			6 677	-50 934	35 673
Tax Increase Decrease From Effect Dividends From Companies									-11 235 116	-25 378 259
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss				4 914	945			558	-17 337	-2 639
Tax Tax Credit On Profit Or Loss On Ordinary Activities				171 208	50 690			52 280	392 844	377 063
Total Additions Including From Business Combinations Property Plant Equipment						150 753	672 141	457 721
Total Assets Less Current Liabilities	2 421 841	4 514 780	3 896 230	3 777 863	2 579 121	3 094 138	3 377 582	46 155 458	45 208 151	46 771 201
Total Current Tax Expense Credit								68 763	376 637	357 955
Total Operating Lease Payments								142 188	200 557	153 780
Trade Creditors Trade Payables				41 980	108 640	69 887	177 119	51 191	72 060	156 006
Trade Debtors Trade Receivables				1 253 344	1 715 485	2 097 032	2 217 764	3 132 887	2 645 547	3 262 749
Transfers To From Retained Earnings Increase Decrease In Equity										39 001 549
Turnover Revenue				7 989 657	8 137 497			10 777 402	10 921 822	12 403 023
Wages Salaries	947 446	997 092	1 025 427	1 152 665	913 214			2 137 431	1 985 332	2 160 403
Company Contributions To Defined Benefit Plans Directors								12 714	13 326	13 432
Director Remuneration								176 570	204 355	294 401
Director Remuneration Benefits Including Payments To Third Parties								189 284	217 681	307 833
Total Fees To Auditors	12 000	13 500	12 000
Accruals Deferred Income Within One Year	915 886	1 478 727	979 283	1 078 521
Amortisation Intangible Assets Expense	134 033	253 020	207 736	156 404
Amounts Owed To Parent Undertaking Within One Year	407 743	1 753 715	430 061	339 857
Amounts Written Off Back Investments		481 774	744 482
Commitments Under Non-cancellable Operating Leases Land Buildings	-46 529	-46 529	-49 336	-11 097
Commitments Under Non-cancellable Operating Leases Other Items	-145 242	-268 682	-134 217	-83 637
Corporation Tax Due Within One Year	5 580	-3 976		25 200
Corporation Tax Recoverable Current Asset			75 227	167 512
Creditors Due After One Year		1 995 284	1 963 285	1 463 283
Creditors Due Within One Year	2 150 630	3 700 680	1 787 275	1 812 782
Debtors Due Within One Year	1 653 095	2 959 845	1 733 251	1 552 383
Depreciation Tangible Fixed Assets Expense	236 125	233 774	274 420	349 963
Difference Between Accumulated Depreciation Amortisation Capital Allowances	4 334	10 191	56 076	247 589
Expenses Not Deductible For Tax Purposes	17 190	6 370	7 434	4 914
Foreign Currency Translation Gain Loss Recognised In Profit Loss	-3 933	-2 436	2 214	-19 855
Intangible Fixed Assets Additions		1 963 285
Intangible Fixed Assets Aggregate Amortisation Impairment	402 099	1 136 893	2 089 111	2 245 515
Intangible Fixed Assets Amortisation Charged In Period		253 020	207 736	156 404
Intangible Fixed Assets Cost Or Valuation	1 206 297	3 169 582	3 169 582	3 169 582
Intangible Fixed Assets Impairment Losses		481 774	744 482
Interest Payable Similar Charges	296	31 999	47 904	45 716
Land Buildings Operating Leases Expiring Between Two Five Years	-46 529	-46 529	-30 312
Land Buildings Operating Leases Expiring Within One Year			-19 024	-11 097
Net Assets Liability Excluding Pension Asset Liability	2 419 616	2 511 414	1 876 869	2 112 497
Number Shares Allotted		50 000	50 000	50 000
Obligations Under Finance Leases Hire Purchase Contracts Between Two To Five Years			-1 963 285	-1 463 283
Other Interest Receivable			101	1 062
Other Interest Receivable Similar Income			101	1 062
Other Operating Income	120 000	120 000	120 000	120 000
Other Operating Leases Expiring Between Two Five Years	-115 182	-227 459	-101 187	-69 336
Other Operating Leases Expiring Within One Year	-30 060	-41 223	-33 030	-14 301
Other Taxation Social Security Within One Year	345 347	322 748	248 317	314 865
Other Timing Differences	-2 109	-2 109
Pension Costs	71 223	92 255	75 904	85 290
Pensions Costs Defined Contribution Schemes	71 223	92 255	75 904	85 290
Prepayments Accrued Income Current Asset	73 238	141 343	112 715	127 251
Profit Loss For Period	161 872	91 798	-634 545	235 628
Provisions Charged Credited To Profit Loss Account During Period		5 857	47 994	146 007
Provisions For Liabilities Charges	2 225	8 082	56 076	202 083
Share Capital Allotted Called Up Paid	50 000	50 000	50 000	50 000
Staff Costs	1 189 468	1 313 809	1 333 528	1 455 701
Tangible Fixed Assets Additions		478 359	463 543	682 177
Tangible Fixed Assets Cost Or Valuation	3 746 175	4 039 693	4 220 586	4 599 348
Tangible Fixed Assets Depreciation	2 462 127	2 523 951	2 594 203	2 790 108
Tangible Fixed Assets Depreciation Charged In Period		233 774	274 420	349 963
Tangible Fixed Assets Depreciation Decrease Increase On Disposals		171 950	204 168	154 058
Tangible Fixed Assets Disposals		184 841	282 650	303 415
Tax On Group Profit On Ordinary Activities Standard U K Tax Rate	-28 817	-40 516	157 848	-85 436
Tax On Profit Or Loss On Ordinary Activities	-51 038	77 018	-23 156	171 208
Total U K Foreign Current Tax After Adjustments Relief	73 297	71 161	-71 161	25 200
Trade Creditors Within One Year	476 074	149 466	129 614	54 339
Turnover Gross Operating Revenue	6 458 183	12 370 608	8 537 391	7 989 657
U K Current Corporation Tax	-73 297	-71 161	71 161	-25 200
U K Current Corporation Tax On Income For Period	73 297	71 161	-71 161	25 200
Utilisation Tax Losses				28 757

Company staff

Floriane G.

Role: Director

Appointed: 16 July 2024

Latest update: 25 June 2025

Roberto N.

Role: Director

Appointed: 16 July 2024

Latest update: 25 June 2025

James D.

Role: Director

Appointed: 22 June 2022

Latest update: 25 June 2025

Craig G.

Role: Director

Appointed: 24 October 2016

Latest update: 25 June 2025

William B.

Role: Director

Appointed: 24 October 2016

Resigned: 30 June 2022

Latest update: 25 June 2025

Alessandro C.

Role: Director

Appointed: 24 October 2016

Resigned: 31 August 2024

Latest update: 25 June 2025

Damiano W.

Role: Director

Appointed: 04 December 2013

Resigned: 24 October 2016

Latest update: 25 June 2025

James O.

Role: Secretary

Appointed: 11 February 2011

Resigned: 03 January 2012

Latest update: 25 June 2025

Christopher L.

Role: Director

Appointed: 10 September 2007

Resigned: 25 May 2016

Latest update: 25 June 2025

Christopher T.

Role: Director

Appointed: 10 September 2007

Resigned: 04 December 2013

Latest update: 25 June 2025

Elizabeth M.

Role: Director

Appointed: 07 September 2007

Resigned: 18 November 2010

Latest update: 25 June 2025

Kevin D.

Role: Secretary

Appointed: 29 September 2006

Resigned: 29 June 2008

Latest update: 25 June 2025

Tom E.

Role: Director

Appointed: 03 July 2006

Resigned: 10 September 2007

Latest update: 25 June 2025

Kevin D.

Role: Director

Appointed: 03 July 2006

Resigned: 10 September 2007

Latest update: 25 June 2025

Manfred D.

Role: Director

Appointed: 27 April 2005

Resigned: 16 June 2006

Latest update: 25 June 2025

Brenda B.

Role: Director

Appointed: 01 September 2002

Resigned: 15 June 2006

Latest update: 25 June 2025

Ronald R.

Role: Director

Appointed: 01 September 2002

Resigned: 10 September 2007

Latest update: 25 June 2025

Daniel B.

Role: Director

Appointed: 12 July 2001

Resigned: 18 April 2005

Latest update: 25 June 2025

William G.

Role: Director

Appointed: 01 May 2000

Resigned: 13 September 2002

Latest update: 25 June 2025

Alain D.

Role: Director

Appointed: 01 May 2000

Resigned: 01 August 2001

Latest update: 25 June 2025

David U.

Role: Director

Appointed: 05 March 1998

Resigned: 11 May 2000

Latest update: 25 June 2025

John B.

Role: Director

Appointed: 16 January 1995

Resigned: 21 November 1997

Latest update: 25 June 2025

John W.

Role: Director

Appointed: 28 June 1992

Resigned: 30 January 1998

Latest update: 25 June 2025

James P.

Role: Director

Appointed: 28 June 1992

Resigned: 13 September 2002

Latest update: 25 June 2025

Geoffrey L.

Role: Director

Appointed: 28 June 1992

Resigned: 07 January 1998

Latest update: 25 June 2025

Brenda B.

Role: Secretary

Appointed: 28 June 1992

Resigned: 15 October 2006

Latest update: 25 June 2025

People with significant control

The companies that control this firm are: Haemonetics Corporation owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Boston at Summer Street, 02110, Massachusetts and was registered as a PSC under the registration number 04-2882273.

Haemonetics Corporation

Address: 125 Summer Street, Boston, Massachusetts, 02110, United States

Legal authority United States

Legal form Corporate

Country registered United States

Place registered United States

Registration number 04-2882273

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	12 July 2024
Confirmation statement last made up date	28 June 2023

Annual Accounts 4 December 2013
Start Date For Period Covered By Report	2012-04-01
End Date For Period Covered By Report	2013-03-31
Date Approval Accounts	4 December 2013
Annual Accounts 10 November 2014
Start Date For Period Covered By Report	2013-04-01
End Date For Period Covered By Report	2014-03-31
Date Approval Accounts	10 November 2014
Annual Accounts 22 March 2016
Start Date For Period Covered By Report	2014-04-01
End Date For Period Covered By Report	2015-03-31
Date Approval Accounts	22 March 2016
Annual Accounts
Start Date For Period Covered By Report	2015-04-01
End Date For Period Covered By Report	2016-03-31
Annual Accounts
Start Date For Period Covered By Report	2016-04-01
Annual Accounts
Start Date For Period Covered By Report	2017-04-01
End Date For Period Covered By Report	2018-03-31
Annual Accounts
Start Date For Period Covered By Report	2018-04-01
End Date For Period Covered By Report	2019-03-31
Annual Accounts
Start Date For Period Covered By Report	2019-04-01
End Date For Period Covered By Report	2020-03-31
Annual Accounts
Start Date For Period Covered By Report	2020-04-01
End Date For Period Covered By Report	2021-03-31
Annual Accounts
End Date For Period Covered By Report	2017-03-31

Support & Implementation Specialist in Coventry, posted on Thursday 30th November 2017
Region / City	Midlands, Coventry
Industry	medical supplies
Experience	at least one year
Job type	full time
Career level	experienced (non-managerial)


Territory Sales Manager in Coventry, posted on Thursday 24th December 2015
Region / City	Midlands, Coventry
Industry	medical supplies
Job type	full time
Career level	supervising

Haemonetics Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Floriane G.

Roberto N.

James D.

Craig G.

William B.

Alessandro C.

Damiano W.

James O.

Christopher L.

Christopher T.

Elizabeth M.

Kevin D.

Tom E.

Kevin D.

Manfred D.

Brenda B.

Ronald R.

Daniel B.

William G.

Alain D.

David U.

John B.

John W.

James P.

Geoffrey L.

Brenda B.

People with significant control

Haemonetics Corporation

Accounts Documents

Jobs and Vacancies at Haemonetics Ltd

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies